Melisa Ece Zeylan

Ms. Melisa Ece Zeylan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
DODamla Ovek
Damla Ovek
ZAZeynep Abali
Zeynep Abali
MZMelisa Ece Zeylan
Melisa Ece Zeylan
OKOzlem Keskin
Ozlem Keskin
AGAttila Gursoy
Attila Gursoy
NTNurcan Tuncbag
Nurcan Tuncbag

22 January 2024 in Journal of Proteome Research
Verified
Journal Article
Open access
MZMelisa Ece Zeylan
Melisa Ece Zeylan
SSSimge Senyuz
Simge Senyuz
PPPol Picón-Pagès
Pol Picón-Pagès
AGAnna García-Elías
Anna García-Elías
MTMarta Tajes
Marta Tajes
AGAttila Gursoy
Attila Gursoy
One of the primary goals of systems medicine is the detection of putative proteins and pathways involved in disease progression and pathological phenotypes. Vascular cognitive impairment (VCI) is a heterogeneous condition manifesting as cognitive impairment resulting from vascular factors. The precise mechanisms underlying this relationship remain unclear, which poses challenges for experimental research. Here, we applied computational approaches like systems biology to unveil and select relevant proteins and pathways related to VCI by studying the crosstalk between cardiovascular and cognitive diseases. In addition, we specifically included signals related to oxidative stress, a common etiologic factor tightly linked to aging, a major determinant of VCI. Our results show that pathways associated with oxidative stress are quite relevant, as most of the prioritized vascular cognitive genes and proteins were enriched in these pathways. Our analysis provided a short list of proteins that could be contributing to VCI: DOLK, TSC1, ATP1A1, MAPK14, YWHAZ, CREB3, HSPB1, PRDX6, and LMNA. Moreover, our experimental results suggest a high implication of glycative stress, generating oxidative processes and post-translational protein modifications through advanced glycation end-products (AGEs). We propose that these products interact with their specific receptors (RAGE) and Notch signaling to contribute to the etiology of VCI.

Verified
Journal Article
Open access
PDF file
PPPol Picón
Pol Picón
MBMònica Bosch-Morató
Mònica Bosch-Morató
LSLaia Subirana
Laia Subirana
FRFrancisca Rubio-Moscardó
Francisca Rubio-Moscardó
BGBiuse Guivernau
Biuse Guivernau
Francisco MuñozFrancisco Muñoz
Francisco Muñoz
Alzheimer’s disease (AD) is known to be caused by amyloid β-peptide (Aβ) misfolded into β-sheets, but this knowledge has not yet led to treatments to prevent AD. To identify novel molecular players in Aβ toxicity, we carried out a genome-wide screen in Saccharomyces cerevisiae, using a library of 5154 gene knock-out strains expressing Aβ1–42. We identified 81 mammalian orthologue genes that enhance Aβ1–42 toxicity, while 157 were protective. Next, we performed interactome and text-mining studies to increase the number of genes and to identify the main cellular functions affected by Aβ oligomers (oAβ). We found that the most affected cellular functions were calcium regulation, protein translation and mitochondrial activity. We focused on SURF4, a protein that regulates the store-operated calcium channel (SOCE). An in vitro analysis using human neuroblastoma cells showed that SURF4 silencing induced higher intracellular calcium levels, while its overexpression decreased calcium entry. Furthermore, SURF4 silencing produced a significant reduction in cell death when cells were challenged with oAβ1–42, whereas SURF4 overexpression induced Aβ1–42 cytotoxicity. In summary, we identified new enhancer and protective activities for Aβ toxicity and showed that SURF4 contributes to oAβ1–42 neurotoxicity by decreasing SOCE activity.

6 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MZMelisa Ece Zeylan
Melisa Ece Zeylan
SSSimge Senyuz
Simge Senyuz
PPPol Picón-Pagès
Pol Picón-Pagès
AGAnna García-Elías
Anna García-Elías
MTMarta Tajes
Marta Tajes
AGAttila Gursoy
Attila Gursoy
One of the primary goals of systems medicine is detecting putative proteins and pathways involved in disease progression and pathological phenotypes. Vascular Cognitive Impairment (VCI) is a heterogeneous condition manifesting as cognitive impairment resulting from vascular factors. The precise mechanisms underlying this relationship remain unclear, which poses challenges for experimental research. Here, we applied computational approaches like systems biology to unveil and select relevant proteins and pathways related to VCI by studying the crosstalk between cardiovascular and cognitive diseases. In addition, we specifically included signals related to oxidative stress, a common etiologic factor tightly linked to aging, a major determinant of VCI. Our results show that pathways associated with oxidative stress are quite relevant, as most of the prioritized vascular-cognitive genes/proteins were enriched in these pathways. Our analysis provided a short list of proteins that could be contributing to VCI: DOLK, TSC1, ATP1A1, MAPK14, YWHAZ, CREB3, HSPB1, PRDX6, and LMNA. Moreover, our experimental results suggest a high implication of glycative stress, generating oxidative processes and post-translational protein modifications through advanced glycation end-products (AGEs). We propose that these products interact with their specific receptors (RAGE) and Notch signaling to contribute to the etiology of VCI.

8 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MZMelisa Ece Zeylan
Melisa Ece Zeylan
SSSimge Senyuz
Simge Senyuz
OKOzlem Keskin
Ozlem Keskin
AGAttila Gursoy
Attila Gursoy
Vascular cognitive impairment (VCI) is an understudied cerebrovascular disease. As it can result in a significant amount of functional and cognitive disabilities, it is vital to reveal proteins related to it. Our study focuses on revealing proteins related to this complex disease by deciphering the crosstalk between cardiovascular and cognitive diseases. We build protein-protein interaction networks related to cardiovascular and cognitive diseases. After merging these networks, we analyze the network to extract the hub proteins and their interactors. We found the clusters on this network and built the structural protein-protein interaction network of the most connected cluster on the network. We analyzed the interactions of this network with molecular modeling via PRISM. PRISM predicted several interactions that can be novel in the context of VCI-related interactions. Two mutant forms of APP (V715M and L723P), previously not connected to VCI, were discovered to interact with other proteins. Our findings demonstrate that two mutant forms of APP interact differently with TP53 and MAPK’s. Furthermore, TP53, AKT1, PARP1, and FGFR1 interact with MAPKs through their mutant conformations. We hypothesize that these interactions might be crucial for VCI. We suggest that these interactions and proteins can act as early VCI markers or as possible therapeutic targets.

6 November 2025 in bioRxiv
Verified
Preprint
Open access
PBPatricia M. Bota
Patricia M. Bota
PPPol Picón-Pagès
Pol Picón-Pagès
HFHugo Fanlo-Ucar
Hugo Fanlo-Ucar
SASaja Almabhouh
Saja Almabhouh
OBOriol Bagudanch
Oriol Bagudanch
BOBaldo Oliva
Baldo Oliva
Astrocytes are central to brain homeostasis, supporting neuronal metabolism, synaptic activity, and the blood–brain barrier. With aging, these glial cells undergo molecular and functional changes that weaken support functions and promote neuroinflammation, contributing to neurodegeneration. Yet the systems-level mechanisms of astrocytic aging remain poorly defined in human models. Because aging also heightens risk for cardiovascular disease, cognitive impairment, type 2 diabetes, and systemic inflammation, clarifying shared astrocytic pathways is critical for understanding brain–body crosstalk. Using an in vitro human astrocyte model exposed to sublethal oxidative stress (10 µM H₂O₂), we profiled transcriptomic changes and identified differentially expressed genes across antioxidant defences, proteostasis, transcriptional regulation, vesicular trafficking, and inflammatory signalling. We then performed seven network-prioritization analyses on a curated human protein–protein interactome: one seeded with the astrocyte H₂O₂-responsive genes and six with phenotype-associated gene sets (Alzheimer’s disease, cardiovascular disease, cognitive impairment, type 2 diabetes, oxidative stress, and inflammation). Intersecting the top 5% scoring genes from each run yielded a 127-gene core shared across all seven, enriched for proteostasis, DNA repair, mitochondrial regulation, and telomere and nuclear envelope maintenance. Structure-guided analyses highlighted vulnerable interfaces, including lamin A/C–lamin B1, α-actinin–filamins, 14-3-3 dimers, and aminoacyl-tRNA synthetase assemblies, where pathogenic variants are predicted to destabilize or aberrantly stabilize protein interactions. Structure-based interface predictions also highlight potential interactions between APP–VCP/p97 and p53–14-3-3ζ that link proteostasis and stress signalling. Together, these findings define a conserved astrocytic vulnerability network that may couple neurodegeneration with cardiovascular disease and nominate structurally testable targets for biomarkers and interventions.